NASHVILLE, Tenn., July 10, 2019 /PRNewswire/ -- Stratasan, LLC ("Stratasan" or the "Company"), a Nashville-based healthcare data analytics software provider, i

CLEVELAND, July 10, 2019 /PRNewswire/ -- Centerline Biomedical, Inc. (Centerline) has announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship product, the Intra-Operative Positioning System, IOPS.

NORTHBROOK, Ill., July 10, 2019 /PRNewswire/ -- Astellas today announced that Chelsea Glinski has been appointed national vice president, Oncology Sales, Astellas US. In this role, Glinski will oversee US sales for the XTANDI brand, and contribute to the growth and development of the oncology sales organization overall.

ROLLING MEADOWS, Ill., July 10, 2019 /PRNewswire/ -- Arthur J. Gallagher & Co. today announced the acquisition of BluePeak Advisors, LLC. Terms of the transaction were not disclosed.

BAY CITY, Mich., July 10, 2019 /PRNewswire/ -- Lansing-based Green Peak Innovations (GPI) is opening its first of 30 planned Michigan Skymint stores on July 10 in Bay City.  The store will feature the highest quality medical marijuana and marijuana products in a contemporary, thoughtful and inviting sett

NEW YORK, July 10, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that Dr. Miriam Kidron, Chief Scie

CHARLOTTE, N.C., July 10, 2019 /PRNewswire/ -- CBD is a booming industry. Some news outlets have gone on to say that it is the next gold rush. As a whole, the CBD industry has been growing rapidly over the past few years and is projected to be worth $22 billion in the next three years. While that is staggering on its own, the fact that it wa

DURHAM, N.C., July 10, 2019 /PRNewswire/ -- Biomarck Pharmaceuticals, Ltd today announced that statistical significance (p=0.02) was achieved in improvement of Overall Response Rate (ORR) in the BIO-11006/SOC group compared to standard of care alone at 3 months in the Phase 2 study in NSCLC. This study compares standard of care alone, (pemetrexed/carboplatin; SOC) to SOC

MILPITAS, Calif., July 10, 2019 /PRNewswire/ -- Nearly 36 percent of patients with a tick-borne disease spent more than $10,000 on tests, treatments, appointments, and other costs associated with their disease, a new IGeneX

CARROLLTON, Texas, July 10, 2019 /PRNewswire/ -- Fry Construction, Inc., specialist in the precision construction of medical facilities, attends Varian Medical Systems' first annual Medical Contractors' Forum.Varian held their first forum specifically planned for medical construction contractors specializing in radiotherapy buildouts, earlier this ye